U.S. Auto Components Stock News

In March 2026, Microvast Holdings, Inc. reported fourth-quarter 2025 sales of US$96.4 million, full-year sales of US$427.52 million, a sharply lower annual net loss of US$29.22 million, and issued 2026 guidance pointing to continued revenue growth while citing tariff, regulatory, and geopolitical headwinds. On the same day, auditor Deloitte Touche Tohmatsu CPA Ltd issued an unqualified opinion but raised doubt about Microvast’s ability to continue as a going concern, highlighting a tension...

General Mills (GIS) has just posted its Q3 2026 numbers, with revenue at US$4.4b and basic EPS of US$0.57, set against a trailing twelve month EPS of US$4.07 on revenue of US$18.4b. Over recent quarters the company has seen revenue move from US$4.8b in Q2 2026 and US$4.5b in Q1 2026 to the latest US$4.4b print, while basic EPS shifted from US$0.77 and US$2.22 in those periods to US$0.57. This sets up a results season where investors are likely to focus squarely on how margins are holding up...

Earlier in March 2026, PPG Industries launched its PPG AQUACRON Waterborne Shop Primers for structural steel and marked its 200th electrostatic application of PPG SIGMAGLIDE 2390 marine fouling control coatings, both aimed at faster curing, lower emissions and improved application efficiency. These advances underscore PPG’s push to offer coatings that cut labor, material use and carbon impact for industrial and marine customers, potentially strengthening its position in...

Gilead Sciences has agreed to acquire blood cancer drug developer Arcellx in a transaction valued at $7.8 billion. The deal is structured with a substantial upfront cash payment and additional milestone payments tied to future sales. The acquisition is intended to expand Gilead's cell-based therapies pipeline and deepen its presence in oncology. Gilead Sciences, traded as NasdaqGS:GILD, is moving to widen its reach in cancer treatments with this planned Arcellx acquisition. The company is...

If you are wondering whether Booking Holdings at around US$4,381 per share still offers value, you are not alone and the answer depends on how you look at the numbers. The stock has seen mixed returns, with a 1.4% gain over the last 7 days and 5.8% over the past month, set against a 17.7% decline year to date and a 3.9% decline over the last year. These moves are playing out as Booking Holdings continues to sit at the center of global travel and online bookings. Investor sentiment often...

If you are wondering whether Realty Income at around US$63.04 is offering fair value or a potential mispricing, this article walks through what the current data suggests. The stock has a mixed recent run, with a 2.6% decline over the last 7 days and a 4.0% decline over 30 days, yet it sits on returns of 10.0% year to date and 18.0% over 1 year. Recent attention on Realty Income has been driven by its role as a large U.S. real estate investment trust and an ongoing focus on its dividend...

Recent share performance and context Universal Display (OLED) has been under pressure recently, with the stock showing a 24% decline over the past month and a 17% decline over the past 3 months. This has prompted investors to reassess the business. See our latest analysis for Universal Display. The recent slide fits into a tougher year for holders, with the share price down meaningfully year to date and the 1 year total shareholder return of a 37.23% decline pointing to fading momentum,...

BlackRock (BLK) has drawn fresh attention after launching the iShares Staked Ethereum Trust ETF, ETHB. This gives stock investors a new reference point for how the firm is approaching crypto related products. See our latest analysis for BlackRock. Despite the crypto product headlines, BlackRock’s share price has had a softer patch, with a 30 day share price return of 9.63% and a year to date share price return of 10.76%. The 1 year total shareholder return of 3.24% and 3 year total...

Insmed (NasdaqGS:INSM) has launched Brinsupri, also known as brensocatib, for non cystic fibrosis bronchiectasis. Brinsupri is the first approved therapy for this condition and has already generated significant initial sales. The successful launch marks a material commercial milestone for Insmed and adds a new revenue stream alongside its existing portfolio. Insmed focuses on treatments for serious and rare respiratory diseases, so the approval and rollout of Brinsupri fit directly into its...

Earlier in March 2026, Bristol Myers Squibb reported positive interim Phase 3 SUCCESSOR-2 results for oral mezigdomide in relapsed or refractory multiple myeloma, and separately secured U.S. FDA approval for Sotyktu to treat adults with active psoriatic arthritis. Together, these milestones highlight Bristol Myers Squibb’s efforts to extend its leadership in targeted protein degradation and expand Sotyktu’s reach into immune-mediated diseases. We’ll now examine how the mezigdomide...

AngloGold Ashanti reported record 2025 output of 500,000 ounces at its Sukari mine, now classified as a Tier 1 asset and contributing 16% of group production after the Centamin acquisition. This surge in Sukari’s importance, combined with ongoing efficiency work under the Full Asset Potential program, is drawing increased attention from analysts ahead of the upcoming earnings release. We’ll now examine how Sukari’s record production and growing role in AngloGold Ashanti’s portfolio affects...

Recent performance context for Exxon Mobil (XOM) Exxon Mobil (XOM) has drawn investor attention after recent share price moves, with a past 3 months total return of 35.2% and a 1 year total return of 41.2%. Over the past month the stock returned 6.2%, while the past week showed a 4.0% gain following a modest 0.8% decline in the last trading day. See our latest analysis for Exxon Mobil. Viewed together, Exxon Mobil’s recent share price return of 3.96% over 7 days and 6.16% over 30 days sits on...

Carter's (CRI) has attracted investor attention after recent trading saw the share price at $34.51, with mixed return patterns over the past year prompting closer scrutiny of the childrenswear company’s fundamentals and valuation. See our latest analysis for Carter's. The recent pullback, including a 13.83% 1 month share price return and an 11.67% 1 year total shareholder return, suggests momentum has cooled after a modest 3.95% year to date share price gain. If Carter's price action has you...

The recent conflict in Iran has disrupted fertilizer shipments through the Strait of Hormuz, tightening global nitrogen supply just as CVR Partners entered 2026 with an unusually strong order book and earlier-than-normal ammonia movements across key farming regions. This combination of supply constraints and accelerated demand has created one of the strongest pricing backdrops for CVR Partners’ nitrogen fertilizers in years, underscoring how geopolitics can abruptly reshape fundamentals in a...

Capital Clean Energy Carriers (CCEC) recently sold 12 container vessels, raised about US$472.2 million in net proceeds, and redirected that capital into gas transportation assets, including newbuilding LNG carriers on long-term charters. See our latest analysis for Capital Clean Energy Carriers. Despite the recent asset sales and LNG charter wins, the share price is around US$20.21 with a 30 day share price return of about an 11% decline. The 1 year total shareholder return of 5.67% and 3...

Walker & Dunlop stock moves after extended share price slide Walker & Dunlop (WD) is drawing fresh attention after a sharp share price slide, with the stock showing negative returns over the past month, past 3 months, year to date, and past year. See our latest analysis for Walker & Dunlop. The 30 day share price return of 27.48% and 90 day share price return of 27.21% underline a clear loss of momentum. At the same time, the 1 year total shareholder return of 45.38% and 5 year total...

On March 18, 2026, Ingredion Incorporated announced its board declared a quarterly dividend of US$0.82 per share payable April 21, 2026, and confirmed a global AI-driven R&D collaboration with Shiru to develop novel natural prebiotic and functional protein ingredients for food, beverage, supplements, and specialized nutrition customers. This tie-up gives Shiru access to Ingredion’s scale and 18,000-plus customer relationships across 120 countries, potentially speeding real-world adoption of...

If you are wondering whether Reddit's current share price really reflects what you are getting as an investor, this article looks closely at what the numbers indicate about value. Reddit recently closed at US$142.79, with returns of 4.1% over the last 7 days, 2.2% over 30 days, a 41.0% decline year to date, and 29.9% over the last year. Recent headlines have focused on Reddit's position as a major online community platform and its ongoing role in broader market conversations. These stories...

comScore FY 2025 earnings snapshot comScore (SCOR) just closed out FY 2025 with Q4 revenue of US$93.5 million and basic EPS of US$12.77, alongside full year trailing twelve month figures showing revenue of US$357.5 million and a net loss of US$101.8 million. Over recent quarters the company has seen revenue move in a narrow band between US$85.7 million and US$94.9 million per quarter. At the same time, basic EPS has swung from a loss of US$12.79 to a profit of US$12.77. This leaves investors...

Spyre Therapeutics (SYRE) is back in focus after completing recruitment for the rheumatoid arthritis arm of its SKYWAY Phase 2 trial, which has pulled forward the expected topline readout to the third quarter of 2026. See our latest analysis for Spyre Therapeutics. At a share price of $43.06, Spyre’s momentum has been strong, with a 30 day share price return of 17.55% and a 90 day gain of 28.65%. The 1 year total shareholder return of 134.02% and 3 year total shareholder return above 4x...

Infleqtion (NYSE:INFQ) has delivered the UK’s first operational 100-qubit quantum computer to the National Quantum Computing Centre. The system is based on Infleqtion’s Sqale platform and is the only operational 100-physical-qubit quantum computing system currently installed in a UK national facility. This deployment gives UK researchers and industry direct access to larger scale neutral atom hardware for benchmarking and application testing. For investors watching quantum hardware,...

In March 2026, Enphase Energy announced collaborations with Ensol in France, Vistra in Texas, and Capital Good Fund in the US to expand IQ Battery and microinverter deployments via subscription models, virtual power plants, and enhanced financing access. These partnerships highlight Enphase’s push to embed its hardware into grid services and community-based programs, potentially deepening recurring, service-oriented revenue streams. Next, we’ll examine how Enphase’s expanded virtual power...

Peabody Energy (BTU) is back in focus after a sharp move in global coal prices linked to Middle East supply disruptions, with rising Asian demand aligning with its seaborne growth plans and the ramp up of the Centurion mine. See our latest analysis for Peabody Energy. The recent 2.4% 1 day share price return, on top of a 20.5% 90 day share price return and a very large 5 year total shareholder return, suggests momentum is building as investors reassess Peabody Energy’s risk and growth profile...

Earlier this month, Littelfuse, Inc. amended and restated its credit agreement, increasing its senior unsecured revolving credit facility from US$700 million to US$800 million and extending the maturity to March 12, 2031, while also appointing Trane Technologies executive Holly B. Paeper to its board and Technology Committee. The larger, longer-dated revolving credit line and addition of a board member with deep electrification and thermal management experience could shape how Littelfuse...